http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2006264637-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ffd347c9b8d78db6a3bc767e2a1048f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2006-07-06^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-02-02^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04c1c078c7a1cdc803c47f15941e88f9
publicationDate 2012-02-02^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2006264637-B2
titleOfInvention Core 2 beta(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis
abstract A method of indicating the presence of atherosclerosis (particularly coronary artery atherosclerosis) in a subject is provided, comprising comparing the level of Core 2 GIcNAc-T in a tissue sample from a subject with a reference level determined for the same tissue. A level of Core 2 GIcNAc-T in the tissue sample from a subject that is higher than that of the reference level being indicative that the subject is afflicted with atherosclerosis (particularly coronary artery atherosclerosis - coronary artery disease - CAD). In preferred embodiments, the sample consists of leukocytes and the protein level is determined as the enzymatic activity using radiolabeled UDP-GIcNAc and a Galβ(1 ,3)-GalNAc derivative.
priorityDate 2005-07-06^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002098563-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0031109-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415829845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16667373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454494035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57455154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4478249
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139

Showing number of triples: 1 to 34 of 34.